Liu, Qi
Chen, Junqiang
Xu, Yuanji
Shen, Wenbin
Ye, Jinjun
Luo, Honglei
Zhang, Xizhi
Liu, Wenyang
Xu, Yujin
Zhang, Yingying
Liu, Anwen
Li, Xiaopeng
Ge, Hong
Wang, Qifeng
Luo, Hui
Zhao, Lina
Xie, Conghua
Lin, Qin
Xie, Congying
Xiong, Jianping
Chen, Weiwei
Wang, Luhua
Zhao, Kuaile
Funding for this research was provided by:
National Natural Science Foundation of China (82403210, U22A20326)
Article History
Received: 19 June 2025
Accepted: 3 November 2025
First Online: 18 November 2025
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The study protocol received approval from ethics review boards at Fudan University Shanghai cancer center (No.2109243–13). This study was registered at the Clinicaltrials.gov registry (identification number NCT 05142709). The requirement for written informed consent was waived because this study retrospectively analyzed anonymized patient data.
: Not applicable.